5 results

• Xarelto Reversal Agent Delayed Again, More Clinical Trials May Be Needed

  March 7, 2018

  Irvin Jackson

  The FDA is calling for clinical trials before it will approve the long-delayed Xarelto and Eliquis reversal agent, AndexXa.

• Proposed Xarelto, Eliquis Reversal Agent Raises Questions Among Some Doctors

  December 22, 2016

  Irvin Jackson

  Some doctors are expressing concerns about the safety and efficacy of a proposed reversal agent for the blood thinners Eliquis and Xarelto.

• Proposed Reversal Agent Works For Major Xarelto, Eliquis Bleeding Events: Study

  October 19, 2016

  Irvin Jackson

  A proposed reversal agent for Xarelto and Eliquis stopped 79% of bleeding events suffered by patients after receiving the drugs, according to the findings of a new study.

• Reversal Agent for Uncontrollable Xarelto Bleeding Delayed by FDA

  August 22, 2016

  Irvin Jackson

  A proposed reversal agent for the blood thinners Xarelto and Eliquis suffered a setback this week when the FDA rejected its approval, asking questions about manufacturing and its potential use with similar drugs.

• Portola To Seek Xarelto Reversal Agent Approval Before End of Year

  November 16, 2015

  Irvin Jackson

  The FDA may soon be asked to approve a reversal agent for the blood thinner Xarelto, which has been linked to uncontrollable bleeding events.